Differential expression of peptides serves as an indicator of IgA nephropathy in pediatric patients
Authors:
Open Access
- 9 September 2020
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 20 (5) , 1
Abstract
Peptide profiles change significantly with aging and peptide biomarkers discovered in adult patients may not be suitable for the evaluation of pediatric patients. The present study was designed to explore alterations in the serum peptidome profile of pediatric patients with IgA nephropathy (IgAN). A total of 17 children diagnosed with IgAN were recruited as the experimental group, 11 sex‑matched healthy children were recruited as a healthy control group and 18 sex‑matched children with other glomerular diseases were recruited as a disease control group. Serum peptides of each subject were enriched and analyzed by liquid chromatography with tandem mass spectrometry and the subsequently identified IgAN‑specific peptides were evaluated using Gene Ontology enrichment and Kyoto Encyclopedia of Genes and Genomes pathway analysis. Subsequently, the function of the IgAN‑specific peptides was predicted via sequence comparison with other known functional bioactive peptides. A total of 123 peptides with a fold change >2 (P5 (P<0.05) were identified to be differentially expressed between the pediatric IgAN group and the two other groups. Consequently, two putative peptides that may have bioactive effects in the pathogenesis of IgAN in pediatric patients were identified. The serum peptidome profile of pediatric patients with IgAN was significantly different from the disease control group and the healthy control group. These differentially expressed peptides may serve as biomarkers for the minimally invasive diagnosis of pediatric patients with IgAN. Additionally, the potential bioactive peptides specifically expressed in pediatric IgAN patients that were identified in this study may lay a foundation for exploring new therapies for IgAN, such as the creation of novel peptide drugs.Keywords
This publication has 34 references indexed in Scilit:
- Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profilingBMC Nephrology, 2013
- Identification of a uromodulin fragment for diagnosis of IgA nephropathyRapid Communications in Mass Spectrometry, 2010
- Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral AgentsDiabetes Care, 2010
- Biomarker discovery and clinical proteomicsTrAC Trends in Analytical Chemistry, 2010
- Comprehensive analysis of short peptides in sera from patients with IgA nephropathyRapid Communications in Mass Spectrometry, 2009
- Enteric defensins are essential regulators of intestinal microbial ecologyNature Immunology, 2009
- The human urinary proteome reveals high similarity between kidney aging and chronic kidney diseaseProteomics, 2009
- Peptidomics: Bridging the gap between proteome and metabolomeProteomics, 2006
- IgA NephropathyJournal of the American Society of Nephrology, 2005
- Infant leukemia in Japan: Clinical and biological analysis of 48 casesMedical and Pediatric Oncology, 1991